Canadian Respiratory Journal / 2017 / Article / Tab 4

Research Article

Impaired Hemorheology in Exacerbations of COPD

Table 4

The EImax and SS1/2 values of the groups.

Control group ( = 12) Patient group
( = 13)
Exacerbation group ( = 16)
Before treatmentAfter treatment

EImax0.64 ± 0.210.68 ± 0.240.66 ± 0.370.83 ± 0.1 0.0010.0001
SS2.06 ± 1.293.16 ± 3.654.64 ± 7,926.17 ± 3. 0.00010.0001

Values are expressed as means ± SD; EImax: theoretical EI at infinite shear stress and SS1/2: shear stress at half-maximal deformation. : difference between the control group, before treatment of newly diagnosed COPD, and the exacerbation group; : difference between the control group, after treatment of newly diagnosed COPD, and the exacerbation group; < 0.05: difference from control, < 0.05: difference from before treatment of COPD, and < 0.05: difference from after treatment of COPD. and are findings via ANOVA whereas other symbols are findings by comparison of two groups.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.